Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed May 10, 2012 · 10-Q · 40 days after period end · 0001193125-12-223884
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | -$17.70M | $1.83M |
| EPS Diluted | -$0.78 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 10, 2012 · 40 d after period end
